E-LIB Suche - Ergebnisse für: Joseph Kauer

1

Asciminib Maintains Antibody-Dependent Cellular Cytotoxicit..:

Holzmayer, Samuel J. ; Kauer, Joseph ; Mauermann, Jonas..
Cancers. 16 (2024) 7 - p. 1288 , 2024

Link: https://doi.org/10.3390/..

2

Impact of Clinical Parameters and Induction Regimens on Per..:

Sauer, Sandra ; Hieke, Lennart ; Brandt, Julia...
Transfusion Medicine and Hemotherapy. 50 (2023) 5 - p. 382-395 , 2023

Link: https://doi.org/10.1159/..

3

Autologous Stem Cell Collection after Daratumumab, Bortezom..:

Sauer, Sandra ; Kriegsmann, Katharina ; Nientiedt, Cathleen...
Transfusion Medicine and Hemotherapy. 50 (2023) 5 - p. 371-381 , 2023

Link: https://doi.org/10.1159/..

4

P-076 The impact of heterogeneous disease distribution on M..:

John, Lukas ; Grözinger, Martin ; Sachpekidis, Christos...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S76 , 2023

Link: https://doi.org/10.1016/..

5

Cyclophosphamide etoposide dexamethasone as salvage and bri..:

Kauer, Joseph ; Sester, Lilli Sophie ; Kriegsmann, Katharina...
Hematological Oncology. 41 (2023) 3 - p. 453-462 , 2023

Link: https://doi.org/10.1002/..

6

Stem cell collection after lenalidomide, bortezomib and dex..:

Kauer, Joseph ; Freundt, Emma P. ; Schmitt, Anita...
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

7

P-011 Hematopoietic reconstitution and infections after ant..:

Frenking, Jan ; Kauer, Joseph ; Hajiyianni, Marina...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S38-S39 , 2023

Link: https://doi.org/10.1016/..

8

P-142 Stem cell collection after isatuximab or elotuzumab p..:

Kauer, Joseph ; Freundt, Emma ; Schmitt, Anita...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S113-S114 , 2023

Link: https://doi.org/10.1016/..

9

Identification of CD105 (endoglin) as novel risk marker in ..:

Greiner, Sarah M. ; Märklin, Melanie ; Holzmayer, Samuel...
Annals of Hematology. 101 (2022) 4 - p. 773-780 , 2022

Link: https://doi.org/10.1007/..

10

A novel IgG-based FLT3xCD3 bispecific antibody for the trea..:

Mehta, Naveen K ; Pfluegler, Martin ; Meetze, Kristan...
Journal for ImmunoTherapy of Cancer. 10 (2022) 3 - p. e003882 , 2022

Link: https://doi.org/10.1136/..

11

IgG-Based Bispecific Anti-CD95 Antibodies for the Treatment..:

Hörner, Sebastian ; Moustafa-Oglou, Moustafa ; Teppert, Karin...
Cancers. 14 (2022) 16 - p. 3941 , 2022

Link: https://doi.org/10.3390/..

12

BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic..:

Kauer, Joseph ; Märklin, Melanie ; Pflügler, Martin...
Journal of Cancer Research and Clinical Oncology. 148 (2022) 10 - p. 2759-2771 , 2022

Link: https://doi.org/10.1007/..

13

Expression of the immune checkpoint modulator OX40 indicate..:

Marconato, Maddalena ; Kauer, Joseph ; Salih, Helmut R...
Scientific Reports. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

14

Prolonged Exposure to Oxaliplatin during HIPEC Improves Eff..:

Seyfried, Nick ; Yurttas, Can ; Burkard, Markus...
Cancers. 14 (2022) 5 - p. 1158 , 2022

Link: https://doi.org/10.3390/..

15

CD18 Antibody Application Blocks Unwanted Off-Target T Cell..:

Kauer, Joseph ; Vogt, Fabian ; Hagelstein, Ilona...
Cancers. 13 (2021) 18 - p. 4596 , 2021

Link: https://doi.org/10.3390/..